You are here

A Review of Cardiovascular Risks Associated with Medications Used to Treat Type-2 Diabetes Mellitus

Erin L. St. Onge, PharmD, Carol Anne Motycka, PharmD, and Shannon A. Miller, PharmD
PDF version: 
Patients with type-2 diabetes face a high risk of heart disease. Although insulin, sulfonylureas, metformin, and thiazolidinediones (TZDs) help with glycemic ­control, caution is needed when these agents are prescribed for patients with existing cardiovascular disease.